850 related articles for article (PubMed ID: 27681120)
21. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
[TBL] [Abstract][Full Text] [Related]
22. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.
Cannon M; Philpott NJ; Cesarman E
J Virol; 2003 Jan; 77(1):57-67. PubMed ID: 12477810
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
24. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
Li S; Bai L; Dong J; Sun R; Lan K
Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
[TBL] [Abstract][Full Text] [Related]
26. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.
Tamanaha-Nakasone A; Uehara K; Tanabe Y; Ishikawa H; Yamakawa N; Toyoda Z; Kurima K; Kina S; Tsuneki M; Okubo Y; Yamaguchi S; Utsumi D; Takahashi K; Arakawa H; Arasaki A; Kinjo T
Sci Rep; 2019 Apr; 9(1):6416. PubMed ID: 31015491
[TBL] [Abstract][Full Text] [Related]
27. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495
[TBL] [Abstract][Full Text] [Related]
28. KSHV-Mediated Angiogenesis in Tumor Progression.
Purushothaman P; Uppal T; Sarkar R; Verma SC
Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
[TBL] [Abstract][Full Text] [Related]
29. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection.
Gjyshi O; Bottero V; Veettil MV; Dutta S; Singh VV; Chikoti L; Chandran B
PLoS Pathog; 2014 Oct; 10(10):e1004460. PubMed ID: 25340789
[TBL] [Abstract][Full Text] [Related]
31. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
[TBL] [Abstract][Full Text] [Related]
32. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
33. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.
Holmes DL; Vogt DT; Lagunoff M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
Sadagopan S; Sharma-Walia N; Veettil MV; Raghu H; Sivakumar R; Bottero V; Chandran B
J Virol; 2007 Apr; 81(8):3949-68. PubMed ID: 17287275
[TBL] [Abstract][Full Text] [Related]
35. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
36. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
37. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF; Cesarman E
Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
[TBL] [Abstract][Full Text] [Related]
38. Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.
George Paul A; Sharma-Walia N; Kerur N; White C; Chandran B
Cancer Res; 2010 May; 70(9):3697-708. PubMed ID: 20388794
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
